期刊文献+

NKT细胞激活剂α-Galcer对小鼠红白血病的抑制作用 被引量:3

Inhibitory effect of NKT cell stimulatorα-Galcer on development of erythroleukemia
下载PDF
导出
摘要 (1)目的采用尾静脉注射制备小鼠红白血病模型,探讨α-半乳糖苷神经酰胺(α-Galcer)对红白血病发生和发展的影响。(2)方法体外培养小鼠红白血病细胞系FBL-3,经尾静脉注射接种C57BL/6小鼠。将FBL-3接种小鼠进一步分为α-Galcer处理组和溶剂对照处理组,于FBL-3接种当天分别注射α-Galcer和溶剂DMSO.观察不同处理组FBL-3细胞接种小鼠总体变化,并于FBL-3接种后第8周处死小鼠,观察外周血血象变化和肿瘤结节形成情况。(3)结果与正常小鼠相比,FBL-3细胞接种小鼠实验期间皮肤感染增加。外周血有核红细胞增加,并且出现明显的实体器官肿瘤结节,而α-Galcer处理显著抑制实体器官肿瘤结节的形成。(4)结论通过FBL-3细胞尾静脉注射初步建立红白血病肿瘤小鼠模型,α-Galcer处理对小鼠白血病的发展发挥抑制作用。 Objective To prepare erythroleukemia mouse model through tail vein injection of FBL-3 cell and investigate the effect of a- Galcer on the occurrence and development of erythroleukemia.Methods FBL-3 erythroleukemia cells were cultured in vitro and C57BL/6 erythroleukemia mouse models were prepared by tail vein injection of FBL-3 cells. The FBL-3 injected mice were further divided into two groups by injecting a- Galcerand solvent DMSO respectively on the date of FBL- 3 injection. The overall changes of FBL-3 injected mice in each group were observed during this experiment. 8 weeks after FBL-3 injection, the FBL-3 injected mice were killed and peripheral blood and tumor nodules formation were detected. Results Compared with normal C57BL/6 mice, the FBL-3 injected mice demonstrated obvious skin infection, increased nucleated red blood cells and apparent tumor nodules formation, whilea- Galcer treatment significantly inhibited the formation of tumor nodules on solid organs. Conclusion Erythroleukemia mouse models were prepared preliminarily by tail intravenous injection of FBL-3 cells, and a- Galcer treatment exhibited an inhibitory effect on the development of leukemia in mice.
出处 《华北理工大学学报(医学版)》 2017年第3期169-172,共4页 Journal of North China University of Science and Technology:Health Sciences Edition
基金 华北理工大学大学生创新创业训练计划项目(编号:X2016092) 国家自然科学基金项目(编号:81373111)
关键词 α-半乳糖苷神经酰胺 红白血病 肿瘤小鼠模型 a- Galcer.Erythroleukemia.Tumor mouse model
  • 相关文献

参考文献5

二级参考文献77

  • 1潘玉夏,董作仁,杨琳,温树鹏,乔淑凯,张学军,潘崚,徐世荣.急性髓系白血病患者MMP-2、MMP-9的表达及其临床意义[J].中华血液学杂志,2005,26(8):505-506. 被引量:3
  • 2郭艳珍,孙三霞.急性白血病皮肤损害的临床分析[J].白血病.淋巴瘤,2005,14(4):230-230. 被引量:9
  • 3Friend C. Cell-flee transmission in adult Swiss mice of a disease having the character of leukemia. J Exp Med, 1957 ; 105 (4) : 307 -318.
  • 4Aversa F, Terenzi A, Tabilio A, et aL Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase H study in patients with acute leukemia at high risk of relaps. J Clin Oncol, 2005;23 ( 15 ) : 3447 - 3454.
  • 5Dey BR, Spitzer TR. Current status of haploidentical stem cell transplantation. Br J Haematol, 2006 ; 135 (4) : 423 - 437.
  • 6Rowe JM, Lazarus HM. Genetically haploidentical stem cell transplantation for acute leukemia. Bone Marrow Transplant, 2001 ; 27 (7): 669-676.
  • 7Bendelac A, Savage P B, Teyton L. The biology of NKT cells. Annu Rev Immunol, 2007, 25:297-336.
  • 8Egawa T G, Eberl I, Taniuchi K, et al. Genetic evidence supporting selection of the Valphal4i NKT cell lineage from double-positive thymocyte precursors. Immunity, 2005, 22(6): 705- 716.
  • 9Tahir S M, Cheng O, Shaulov A, et al. Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J Immunol, 2001, 167(7): 4046-4050.
  • 10Tupin E, Kinjo Y, Kronenberg M. The unique role of natural killerT cells in the response to microorganisms. Nat Rev Microbiol, 2007, 5(6): 405- 417.

共引文献17

同被引文献14

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部